Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I Activity  by Tello, Daniel et al.
Cell Metabolism
ArticleInduction of the Mitochondrial NDUFA4L2 Protein
by HIF-1a Decreases Oxygen Consumption
by Inhibiting Complex I Activity
Daniel Tello,1,5 Eduardo Balsa,1,5 Ba´rbara Acosta-Iborra,1 Esther Fuertes-Yebra,1 Ainara Elorza,1 A´ngel Ordo´n˜ez,1
Marı´a Corral-Escariz,1 Ine´s Soro,1 Elia Lo´pez-Bernardo,1 Ester Perales-Clemente,2 Antonio Martı´nez-Ruiz,1
Jose´ Antonio Enrı´quez,2,3 Julia´n Aragone´s,1 Susana Cadenas,1,4 and Manuel O. Landa´zuri1,*
1Servicio de Inmunologı´a, Hospital Universitario de La Princesa, Universidad Auto´noma de Madrid, Instituto de Investigacio´n Sanitaria
Princesa (IIS-IP), Madrid, 28006, Spain
2Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, 28029, Spain
3Departamento de Bioquı´mica y Biologı´a Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza, 50013, Spain
4Departamento de Biologı´a Molecular, Facultad de Ciencias, Universidad Auto´noma de Madrid, Madrid, 28049, Spain
5These authors contributed equally to this work
*Correspondence: mortiz.hlpr@salud.madrid.org
DOI 10.1016/j.cmet.2011.10.008SUMMARY
The fine regulation of mitochondrial function has
proved to be an essential metabolic adaptation to
fluctuations in oxygen availability. During hypoxia,
cells activate an anaerobic switch that favors
glycolysis and attenuates the mitochondrial activity.
This switch involves the hypoxia-inducible tran-
scription factor-1 (HIF-1). We have identified a
HIF-1 target gene, the mitochondrial NDUFA4L2
(NADHdehydrogenase [ubiquinone] 1alphasubcom-
plex, 4-like 2). Our results, obtained employing
NDUFA4L2-silenced cells and NDUFA4L2 knockout
murine embryonic fibroblasts, indicate that hypoxia-
induced NDUFA4L2 attenuates mitochondrial oxy-
gen consumption involving inhibition of Complex I
activity, which limits the intracellular ROS produc-
tion under low-oxygen conditions. Thus, reducing
mitochondrial Complex I activity via NDUFA4L2
appears to be an essential element in the mitochon-
drial reprogramming induced by HIF-1.
INTRODUCTION
Aerobic organisms have developed specific systems to deliver
oxygen to cells in different anatomical locations. However, insuf-
ficient oxygen supply and the ensuing hypoxia is a hallmark of
different pathological situations. In response to hypoxia, cells
activate a metabolic program that reduces oxygen consump-
tion by actively lowering mitochondrial oxidative phosphoryla-
tion (OXPHOS) activity, the main oxygen-consuming process in
most cell types, accompanied by an increase in glucose uptake
and the rate of glycolysis (Aragone´s et al., 2008; Iyer et al., 1998;
Kim et al., 2006; Papandreou et al., 2006). This hypoxic adapta-
tion is due to the expression of genes triggered by hypoxia-
inducible factors (HIFs) (Aragone´s et al., 2009). HIFs are master
transcription factors regulated in an O2-dependent manner
by a family of prolyl hydroxylases (PHDs), which use O2 as768 Cell Metabolism 14, 768–779, December 7, 2011 ª2011 Elseviera substrate to hydroxylate HIF-a subunits in conditions of nor-
moxia (Kaelin and Ratcliffe, 2008). These hydroxylated sub-
strates are then ubiquitinated after recognition by VHL, and
they are degraded by the proteasome. By contrast, PHD activity
is inhibited in hypoxic conditions, and accordingly, HIF-a sub-
units accumulate, heterodimerize with HIF-b, and activate the
expression of HIF-dependent target genes (Schofield and Rat-
cliffe, 2004; Semenza, 2004, 2009).
Among the genes whose expression is upregulated by HIFs
are glucose transporters, like GLUT1, as well as key enzymes
involved in glycolysis (Iyer et al., 1998). The PDK1 and PDK3
genes that code for pyruvate dehydrogenase (PDH) kinases
are also upregulated, which results in increased phosphorylation
and inactivation of PDH, the enzyme that converts pyruvate to
acetyl-CoA (Kim et al., 2006; Lu et al., 2008; Papandreou et al.,
2006). This process limits the substrate available for the tricar-
boxylic acid cycle (TCA) and thus for OXPHOS activity. Mito-
chondrial respiration is also regulated by additional mechanisms
that maximize respiratory efficiency under conditions of reduced
O2 availability. Genes that regulate cytochrome c oxidase (the
ETC Complex IV that reduces O2 to H2O) are also regulated by
HIFs, including COX4-2 isoform and the LON protease, which
produces a switch from isoform COX4-1 to COX4-2 that opti-
mizes the efficiency of respiration under hypoxic conditions
(Fukuda et al., 2007).
Complex I (NADH:ubiquinone oxidoreductase) is the largest
and least understood component of the respiratory chain. This
complex catalyzes the first step in the electron transport chain
(ETC), transferring electrons from NADH to a noncovalently
bound flavin mononucleotide (FMN) and then, via a series of
iron-sulfur clusters (FeS), to the final ubiquinone acceptor. Com-
plex I consists of 45 different subunits that are assembled into
a structure of 1 MDa, and while 7 subunits are encoded by
mitochondrial DNA, the remaining 38 are coded for by the
nuclear genome (Carroll et al., 2006). The activity of the Complex
I is affected by hypoxia, either through posttranslational modifi-
cation (Frost et al., 2005) or the reduced expression of mitochon-
drial genes (Chan et al., 2009). Here we report that HIF-1 induces
the expression of the NADHdehydrogenase (ubiquinone) 1 alpha
subcomplex subunit 4-like 2 gene (NDUFA4L2, also calledInc.
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[NUOMS]), cataloged as a component of ETC Complex I due to
its high sequence identity with NDUFA4. It was previously
described usingmRNA array technology that NDUFA4L2 is over-
expressed in VHL-deficient cell lines and tumors (Favier et al.,
2009; Papandreou et al., 2006), as well as in neuroblastoma cells
in hypoxia (Fredlund et al., 2008) and in pathophysiological con-
ditions like rheumatoid arthritis (Andreas et al., 2009). Although
the physiological function of this protein remains unclear, we
show here that it is involved in lowering mitochondrial oxygen
consumption and Complex I activity, thereby reducing ROS
production. This provides a point in the regulation of mitochon-
drial activity that can reprogram Complex I activity under low-
oxygen conditions.
RESULTS
Hypoxia Induces the Mitochondrial Protein NDUFA4L2
in Primary Cultures and Tumor Cells In Vitro as well as
In Vivo
We hypothesized that, as the principal electron acceptor,
Complex I could be a key regulatory point in the control of the
ETC during hypoxia. To identify Complex I components that
might be regulated by moderate hypoxia, we used an mRNA
array to analyze the expression of genes in HeLa cells main-
tained for short periods of time (6 hr) in 1% O2. We detected
the expression of 44 genes of Complex I in the array: 40 genes
encoded by nuclear DNA and 4 encoded in the mitochondria
(ND1, ND2, ND3, and ND6). Of all these genes, only NDUFA4L2
was clearly induced by hypoxia, whereas the other genes en-
coded by nuclear DNA remained unchanged (Table S1). By
contrast and as described previously (Piruat and Lo´pez-Barneo,
2005), the other mitochondrially encoded genes underwent a
marked downregulation in these hypoxic conditions (Table S1).
It is important to note that NDUFA4L2 gene is strongly induced
by hypoxia. In fact, it appears among the first 12 genes more
induced by hypoxia in the mRNA study (Table S2).
These microarray data were validated by RT-PCR on mRNA
isolated from HeLa and PC-12 cells exposed to hypoxia. Indeed,
RT-PCR assays confirmed that NDUFA4L2 expression was
strongly upregulated in response to hypoxia (Figure 1A), while
such conditions did not change the levels of other Complex I
genes encoded in the nucleus, such as NDUFA4, NDUFAB1,
or NDUFB4, although ND1 and ND6 expression was downregu-
lated (Figure S1A). Upregulation of NDUFA4L2 expression was
also observed in HUVEC and cardiomyocytes subjected to
hypoxia and after treatment with PHD inhibitors such as dime-
thyloxaloylglycine (DMOG) and deferroxamine (Figure 1B). The
efficacy of hypoxia andDMOG in these experiments was corrob-
orated by the marked upregulation of previously recognized HIF
target genes such as PHD3, BNIP3, and GLUT1 (Figure S1B). In
addition, NDUFA4L2 expression was induced in brain tissue of
mice exposed to 7.5% O2 for 18 hr (Figure 1C). An increase in
NDUFA4L2 protein was also evident in response to hypoxia
in different cell types and brain tissue (Figure 1D) with an anti-
body specific to this protein that did not recognize the homolo-
gous NDUFA4 protein (Figure S1C). Moreover, the increase in
NDUFA4L2 protein induced by hypoxia was evident in cardio-
myocytes when assessed by immunofluorescence (Figure 1E).Cell MWe analyzed the cellular localization of NDUFA4L2 in nor-
moxic and hypoxic conditions. A bioinformatics approach pre-
dicted that NDUFA4L2 would be localized in mitochondria
(Table S3), and this prediction was then confirmed experimen-
tally by analyzing mitochondrial and cytoplasmic fractions from
HeLa cells. NDUFA4L2 was clearly enriched in the mitochondrial
fraction under hypoxic conditions (Figure 1F), and immunofluo-
rescence showed a clear colocalization of NDUFA4L2 and cyto-
chrome c in HL-1 cells (Figure 1G), aswell as the colocalization of
NDUFA4L2 and the mitochondria-selective dye MitoTracker in
HeLa cells (Figure S1D). These results confirmed the mitochon-
drial location of NDUFA4L2.
HIF-1a Regulates NDUFA4L2 Induction
To investigate whether hypoxia-induced NDUFA4L2 expression
was mediated by HIF transcription factors, we first silenced
HIF-1b, the common partner of HIF-1a and HIF-2a, thereby im-
pairing the canonical HIF transcriptional response. Interference
of HIF-1b expression abolished the induction of NDUFA4L2
during hypoxia (Figure 2A), as well as the response of PHD3 (in-
cluded as a control of HIF-target gene) (Figure S2A), indicating
that HIF transcriptional activity is essential for NDUFA4L2
induction.
To study the specific role of HIF-1a and HIF-2a in the response
of NDUFA4L2 to hypoxia, we performed RNA interference
assays in human renal carcinoma RCC4 cells that constitutively
stabilize HIF-1a and HIF-2a through the absence of VHL.
Likewise, the response of NDUFA4L2 was also assessed in
RCC4/VHL cells in which VHL expression was restored, and
hence both HIF-1a and HIF-2a were exclusively upregulated in
response to hypoxia. In line with the role of HIF activity in
NDUFA4L2 regulation, there was a robust upregulation of
NDUFA4L2 in hypoxic RCC4/VHL cells, whereas there was
marked and constitutive NDUFA4L2 expression in normoxic
RCC4 cells that was only minimally upregulated in hypoxic con-
ditions (Figure 2B). HIF-1a interference abrogated the expres-
sion of NDUFA4L2 in both normoxic and hypoxic RCC4 cells
(Figure 2B), as well as hypoxia-driven NDUFA4L2 expression in
RCC4/VHL cells (Figure 2B). By contrast, HIF-2a interference
did not affect the expression of NDUFA4L2 in RCC4/VHL cells
exposed to hypoxia, and no significant effect was observed in
RCC4 cells in either normoxic or hypoxic conditions (Figure 2B).
The control experiments for the interference assays showed
a specific reduction of HIF-1a or HIF-2a mRNA expression
(Figure S2B).
We further confirmed these data in mouse embryonic fibro-
blasts (MEFs) from Hif-1a+f/+f/Cre conditional mice in which
HIF-1a was lost after tamoxifen treatment. As a control, we em-
ployed tamoxifen Hif-1a+/+/Cre MEFs that lacked the CRE
recombination sites required for HIF-1a ablation. The hypoxic
induction of Ndufa4l2 expression as well as that of the HIF target
gene Phd3 were only abrogated in Hif-1a+f/+f/Cre conditional
MEFs following tamoxifen exposure, whereas they were still
expressed in Hif-1a+/+/Cre MEFs (Figures 2C and S2C). Hence,
the hypoxic induction of Ndufa4l2 appeared to be mostly medi-
ated by HIF-1a.
To identify possible hypoxia response elements (HREs)
responsible for the induction of NDUFA4L2, the proximal pro-
moter region (intron 1) of NDUFA4L2 was analyzed, identifyingetabolism 14, 768–779, December 7, 2011 ª2011 Elsevier Inc. 769
AB
C D
GE
F
Figure 1. NDUFA4L2 Localizes to Mitochondria and Is Induced in Tumor Cells, in Primary Cultures, and In Vivo by Hypoxia
(A–C) Quantitative RT-PCR analysis ofNDUFA4L2mRNA expression relative to the values in normoxia. HeLa, PC-12, cardiomyocytes, and HUVECwere cultured
under conditions of normoxia or hypoxia (1%O2) for 6 (HeLa) or 18 hr (PC-12, cardiomyocytes, HUVEC) (A and B). DMOGwas added at 1mM (cardiomyocytes) or
0.1 mM (HUVEC), and deferroxamine (DFO) was added at 0.2mM in HUVEC (n = 3). Brain tissue frommice exposed to normoxic (n = 8) or hypoxic (7.5%O2; n = 7)
conditions for 18 hr is shown in (C).
(D) Immunoblot assay of NDUFA4L2 protein in HeLa, PC-12, HUVEC, or rat cardiomyocytes cultured under normoxic or hypoxic conditions (1% O2 for cell
cultures), as well as in brain tissue of mice subjected to hypoxia (7.5%O2) for 18 hr. Tubulin is shown as a loading control. The images are representative of at least
three experiments.
(E) Immunofluorescence showing the increase in NDUFA4L2 protein levels in rat cardiomyocytes exposed to normoxia or hypoxia (1%O2) for 18 hr, with respect
to those maintained in normoxic conditions. The images shown are representative of three experiments.
(F) Immunoblot assay of NDUFA4L2 in total cell (T), cytoplasmic (C), and mitochondrial (M) protein extracts from HeLa cells cultured under normoxic or hypoxic
conditions (1% O2) for 18 hr. Cytochrome c was assayed as a mitochondrial marker. The images shown are representative of three experiments.
(G) Immunofluorescence of HL-1 cells exposed to normoxia or hypoxia (1%O2) for 18 hr. Images show staining for NDUFA4L2 (left panel, green) and cytochrome c
(middle panel, red) and an overlay of the two signals (right panel). The images shown are representative of three experiments. See also Figure S1. n > 3; mean ±
SEM; *p < 0.05; **p < 0.01.
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Figure 2. NDUFA4L2 Induction Is Mediated by HIF-1a
(A) HeLa cells transfected with siRNA against HIF-b or a scramble control were cultured under normoxic or hypoxic (1% O2) conditions for 24 hr. NDUFA4L2
mRNA levels were quantified by real-time RT-PCR.
(B) VHL-deficient RCC4 cells or RCC4/VHL cells were transfected with siRNA against HIF-1a, HIF-2a, or a scramble control and exposed under normoxic or
hypoxic conditions (1% O2) for 24 hr. NDUFA4L2 mRNA levels were quantified by real-time RT-PCR and are expressed relative to normoxic RCC4/VHL.
(C) Hif-1a+/+/Cre MEFs and Hif-1a+f/+f/Cre MEFs in the presence or absence of tamoxifen (1 mM) were cultured under normoxic or hypoxic conditions (1%O2) for
18 hr. NDUFA4L2 mRNA levels were quantified by real-time RT-PCR.
(D) Schematic representation of the human NDUFA4L2 gene and the nucleotide sequences matching the consensus hypoxia response element (HRE) from five
mammalian genes, indicating the regions A-B-C analyzed in the ChIP assay.
(E) ChIP assay of HIF-1a binding to the human NDUFA4L2 gene in HeLa cells cultured in normoxic or hypoxic conditions (1% O2) or exposed to DMOG (0.1 mM)
for 6 hr. RT-PCR quantification is shown of regions A (putative NDUFA4L2 HRE), B (nonconserved HRE), and C (negative HRE) after immunoprecipitation with
HIF-1a or a control antibody, represented as the percentage of that quantified in the total input DNA.
(F) Representative gel of DNA amplified in the ChIP assays shown in (E). See also Figure S2. n > 3; mean ± SEM; *p < 0.05; **p < 0.01.
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highly conserved between different species, unlike the +1344
site. Chromatin immunoprecipitation (ChIP) assays were per-
formed on HeLa cells grown under normoxic or hypoxic condi-
tions and after treatment with DMOG. To evaluate HIF-1aCell Mbinding to NDUFA4L2 regulatory sequences, quantitative PCR
(qPCR) was performed using specific primers for the putative
HRE site (A), the nonconserved HRE site (B), and a negative
site (C). ChIP assays for PDK1, a well-known HIF-1a target,
were also performed as a positive control (Figure S2D). HIF-1aetabolism 14, 768–779, December 7, 2011 ª2011 Elsevier Inc. 771
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Figure 3. NDUFA4L2 Decreases Oxygen Consumption, Membrane
Potential, and ROS Production in Hypoxia
(A–D) HeLa cells were transfected with a scramble control or NDUFA4L2
siRNA and exposed to normoxic or hypoxic (1% O2) conditions for 18–24 hr.
Immunoblot analysis of NDUFA4L2 and HIF-1a protein levels using tubulin and
mitochondrial porin as loading controls is shown in (A). The images are re-
presentative of four independent experiments. Oxygen consumption rates
were measured by high-resolution respirometry (B). HeLa cells were trans-
fected with the empty vector (EV) or pCMV-NDUFA4L2 and then exposed to
normoxic or hypoxic (1% O2) conditions for 24 hr (C and D). Immunoblot
analysis of NDUFA4L2 and myc-tagged protein levels using tubulin and
mitochondrial porin as loading controls are shown (C). The images are re-
presentative of four independent experiments. Oxygen consumption rates
were measured by high-resolution respirometry (D).
(E) Relative DCF fluorescence as a measure of intracellular hydrogen peroxide
levels.
(F) Representative images of four independent experiments showing MitoSOX
intensity as a measure of mitochondrial superoxide levels.
(G and H) Mitochondrial membrane potential was determined with the fluo-
rescent probe TMRE and expressed relative to the control cells in normoxia.
FCCP was used as a positive control of mitochondrial membrane depolar-
ization (n > 3; mean ± SEM; *p < 0.05; **p < 0.01).
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served HRE site (A) was strongly induced by hypoxia and
DMOG treatment (Figure 2E), but not to the nonconserved
HRE site (B) or the negative control region (C). The sequence
amplified by qPCR had the expected size (Figure 2F). Taken
together, these results suggest that NDUFA4L2 is a direct
HIF-1 target gene.
NDUFA4L2 Is Involved in the Hypoxia-Induced Decrease
in Oxygen Consumption and Prevents Increases
in Membrane Potential and ROS Production
during Hypoxia
To test whether NDUFA4L2 is involved in the regulation of mito-
chondrial activity in hypoxia, we first determined the oxygen
consumption in HeLa cells in which NDUFA4L2 was silenced
by specific siRNA. In these experiments, NDUFA4L2 expres-
sion was typically reduced by 80% in hypoxic conditions
(Figure S3A) while NDUFA4 mRNA levels were not affected
by the siNDUFA4L2 (Figure S3B), highlighting the specificity
of the interference of NDUFA4L2. Indeed, NDUFA4L2 inter-
ference reduced its protein expression in both normoxic and
hypoxic conditions (Figure 3A), whereas the expression levels
of proteins from other ETC complexes were unaffected by
NDUFA4L2 interference (Figure S3C). Oxygen consumption
decreased approximately 42% in hypoxic conditions when com-
pared to normoxia in control HeLa cells (Figure 3B). However,
oxygen consumption only decreased by 27% in hypoxic con-
ditions when NDUFA4L2 was silenced in HeLa cells and when
compared to control cells in normoxic conditions (Figure 3B). In
normoxia, NDUFA4L2 silencing increased oxygen consump-
tion by only 10%, probably due to the low normoxic levels of
NDUFA4L2. We also tested whether transient overexpression
of NDUFA4L2 might decrease oxygen consumption by using
a pCMV-NDUFA4L2 vector to achieve expression levels similar
to those obtained in hypoxia (Figures 3C and S3D). Transient
overexpression of NDUFA4L2 decreased oxygen consumption
in HeLa cells by approximately 20% (Figure 3D). Hence, we con-
clude that during hypoxia, NDUFA4L2 induction decreases
oxygen consumption.
Since attenuation of mitochondrial activity in hypoxia may be
a compensatory mechanism to keep mitochondrial ROS under
control, we wondered whether hypoxia-driven NDUFA4L2 up-
regulation could also participate in this antioxidant response.
Previous studies used the fluorescent dye H2DCFDA and flow
cytometry to demonstrate an increase of mitochondrial ROS
production when cells are exposed to low O2 tensions (Brunelle
et al., 2005; Guzy et al., 2005; Mansfield et al., 2005). Accord-
ingly, we observed increased H2DCFDA fluorescence in HeLa
cells exposed to hypoxia (1% O2) that was exacerbated when
NDUFA4L2 was silenced (Figure 3E). Similar data were obtained
using the mitochondrial superoxide indicator MitoSOX (Fig-
ure 3F), which points to the mitochondrial origin of this in-
creased superoxide production, probably from respiratory com-
plexes. Increased ROS production in the absence of NDUFA4L2
during hypoxia correlated with an increased mitochondrial
membrane potential in these conditions (Figure 3G). Conversely,
NDUFA4L2 overexpression significantly decreased membrane
potential compared to cells expressing the empty vector
(Figure 3H).772 Cell Metabolism 14, 768–779, December 7, 2011 ª2011 ElsevierThe Hypoxia-Induced Decrease in Oxygen Consumption
via NDUFA4L2 Occurs through Complex I Inhibition
Given that NDUFA4L2 appears to be a mitochondrial protein
involved in the downregulation of hypoxia-induced oxygen
consumption, and that it likely belongs to the NDUFA4 subunit
family of Complex I, we wondered whether NDUFA4L2 might
be involved in actively regulating Complex I activity. We found
that, when compared to normoxic conditions, Complex I activityInc.
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Figure 4. NDUFA4L2 Decreases Complex I Activity in Hypoxia
(A and B) Complex I activity was measured in HeLa cells transfected with
a scramble control or NDUFA4L2 siRNA (A) or with the empty or pCMV-
NDUFA4L2 vector (B), then exposed to normoxic or hypoxic (1% O2) condi-
tions for 24 hr.
(C and D) Complex IV activity was measured in HeLa cells transfected
with a scramble control or NDUFA4L2 siRNA (C) and the empty or pCMV-
NDUFA4L2 vector (D), then exposed to normoxic or hypoxic (1% O2) condi-
tions for 24 hr.
(E and F) Complex I activity wasmeasured in Hif-1a+f/+f/Cre (E) or Hif-1a+/+/Cre
MEFs (F) maintained in the presence or absence of tamoxifen (1 mM) for 48 hr
and cultured under normoxic or hypoxic (1% O2) conditions for 18 hr.
(G) Blue native PAGE (BN-PAGE) analysis of the mitochondrial OXPHOS
Complex I (NDUFA9), Complex III (Core 2), and Complex IV (CoI) from
scramble and NDUFA4L2 siRNA HeLa cells exposed to normoxic or hypoxic
(1% O2) conditions for 24 hr (n > 3; mean ± SEM; *p < 0.05; **p < 0.01).
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24 hr), although it did not when NDUFA4L2 expression was
silenced (Figure 4A). Moreover, transient overexpression of
NDUFA4L2 decreased Complex I activity in normoxic conditions
(Figure 4B), demonstrating that NDUFA4L2 regulates Complex I
under low-oxygen conditions.
To study the specificity of the effects of NDUFA4L2 on Com-
plex I, we also measured Complex IV activity. Hypoxia (1% O2
for 24 hr) induced a 38% decrease in Complex IV activity inCell MHeLa cells (Figure 4C), but the silencing of NDUFA4L2 expres-
sion in hypoxia or its overexpression in normoxia did not affect
Complex IV activity (Figures 4C and 4D). Similar results were
obtained when Complex IV activity was determined spectropho-
tometrically (data not shown). Hence, NDUFA4L2 appears to
affect ETC activity by specifically inhibiting Complex I. Since
our results indicate that NDUFA4L2 is a HIF-1a-dependent
gene involved in the downregulation of Complex I activity in
hypoxia, we further studied the role of HIF-1 in regulating Com-
plex I. As expected, there was no decrease in Complex I activity
following hypoxia in tamoxifen-treated Hif-1a+f/+f/Cre MEFs in
which HIF-1a was ablated (Figure 4E). By contrast, a decrease
in Complex I activity similar to that seen in HeLa cells was
evident in tamoxifen-treated Hif-1a+/+/Cre MEFs (20%) (Fig-
ure 4F). These results suggest that the HIF-1a-induced in-
crease in NDUFA4L2 expression decreased oxygen consump-
tion through the specific inhibition of mitochondrial Complex I
activity.
Complex I activity can be modulated by its assembly (Vogel
et al., 2005). We hypothesized that hypoxia-induced NDUFA4L2
could affect Complex I assembly. To test this possibility, we
performed Blue native PAGE (BN-PAGE) in order to analyze
the status of mitochondrial complexes. Neither hypoxia nor
NDUFA4L2 silencing modified Complex I content, thus ruling
out the involvement of NDUFA4L2 in the Complex I assembly
process (Figure 4G).
Silencing of NDUFA4L2 Impairs Cell Proliferation in
Hypoxia by Increasing Mitochondrial ROS Generation
While the absence of NDUFA4L2 does not significantly affect
cell proliferation in normoxic conditions (Figure 5A), viable
hypoxic NDUFA4L2-silenced HeLa cells proliferated at a slower
rate than hypoxic control cells (Figure 5B). This slower prolifer-
ation was evident by both cell counting and by direct obser-
vation under the microscope (Figure 5C); it was also observed
in other cell types such as HUVEC, UCD-Mel-N, and SKOV3
cells (Figure S4A). NDUFA4L2-silenced cells did not show
either increased caspase-3 cleavage (Figure 5D) or changes
in propidium iodide incorporation (Figure 5E), excluding the
possibility that NDUFA4L2 silencing impaired cell prolifera-
tion by activating apoptosis. Additional studies showed that
the capacity of hypoxic HeLa cells to form colonies in soft
agar was affected when NDUFA4L2 was silenced, with a
decrease in both the size and the number of colonies (Fig-
ure 5F). In order to investigate whether ROS overproduction
in NDUFA4L2-silenced HeLa cells during hypoxia was re-
sponsible for the impairment in cell proliferation, we tested
the effects of two different antioxidants, N-acetylcysteine
(NAC) and MitoQ (an antioxidant targeted to mitochondria),
on cell proliferation. Cell proliferation was restored when
NDUFA4L2-silenced HeLa cells were treated with MitoQ in
hypoxia (Figure 5G). This effect was also observed with NAC
(Figure S4B), suggesting that exacerbated ROS production
may be involved in the impairment of cell viability under hyp-
oxia. Indeed, an increase in ROS production was detected in
NDUFA4L2-silenced cells exposed to hypoxia using the mito-
chondrial superoxide indicator MitoSOX (Figure 5H). This in-
crease was completely prevented by incubation with MitoQ
(Figure 5H).etabolism 14, 768–779, December 7, 2011 ª2011 Elsevier Inc. 773
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Figure 5. Reduced Hypoxic Levels of NDUFA4L2
Impair Cell Proliferation
(A and B) Growth curves of HeLa cells transfected with
a scramble control or NDUFA4L2 siRNA in normoxic (A)
and hypoxic (0.5% O2) (B) conditions for different periods
of time.
(C) Microscope images showing the density of HeLa cell
cultures transfected with a scramble control or NDUFA4L2
siRNA and maintained under normoxic (21% O2) or
hypoxic (0.5% O2) conditions for 72 hr.
(D) HeLa cells were transfected with either a scramble
control or NDUFA4L2 siRNA and cultured under normoxic
(21%O2) or hypoxic (0.5%O2) conditions for 72 hr, and the
cell lysates were assayed in immunoblots that were pro-
bed with antibodies against NDUFA4L2, uncleaved cas-
pase-3, and cleaved caspase-3. Glut1 was used as a
positive control of hypoxic gene induction and tubulin as
a loading control. Taxol was used as positive control of
apoptosis.
(E) Scramble control or NDUFA4L2 siRNA HeLa cells
maintained in normoxic (21% O2) or hypoxic (0.5% O2)
conditions for 72 hr. The absolute value of apoptosis was
measured by flow cytometry in cells stained with propi-
dium iodide, as described in the Experimental Procedures.
(F) Image of colony formation by HeLa cells transfected
with a scramble control or NDUFA4L2 siRNA in normoxic
and hypoxic (0.5% O2) conditions in soft agar for 15 days.
Both size and number of colonies were quantified.
(G) Growth of HeLa cells transfected with a scramble
control or NDUFA4L2 siRNA in normoxic and hypoxic
(0.5%O2) conditions with or without 0.5 mMMitoQ (0.5 mM
dTPP was used as control of MitoQ) at 72 hr.
(H) Fluorescencemicroscopy images of hypoxic (0.5%O2)
cultured scramble and siNDUFA4L2 HeLa cells treated
either with 0.5 mM MitoQ or 0.5 mM dTPP (n > 3; mean ±
SEM; *p < 0.05; **p < 0.01).
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HeLa cells had increased early S phase and decreased late
S phase compared to scramble control cells (Figure S4C). Since
NDUF4L2-silenced HeLa cells present ROS overproduction in
hypoxia, and ROS can increase the phosphorylation of histone
H2AX, a marker of cell stress (Driessens et al., 2009), we then
analyzed the phosphorylation of H2AX histone. We observed in-
creased phosho-H2AX levels in hypoxia when NDUFA4L2 was
interfered (Figure S4D), suggesting that the lack of NDUFA4L2
in hypoxia produces cell stress.
It has been described that both the downregulation of the iron-
sulfur cluster assembly proteins (ISCU1/2) via miR-210 and the
upregulation of PDK1 are implicated in ROS control and cell
viability in hypoxia (Chan et al., 2009; Chen et al., 2010; Favaro
et al., 2010; Kim et al., 2006; Papandreou et al., 2006). To inves-
tigate the relative contribution of these effects to HeLa hypoxic
adaptation, we performed cell proliferation assays. We only
observed a decrease in ISCU1/2 protein at times over 24 hr at
0.5% (Figure S5A) but not in the milder hypoxic conditions774 Cell Metabolism 14, 768–779, December 7, 2011 ª2011 Elsevier Inc.(1% O2). Furthermore, the overexpression of
ISCU1/2 did not affect HeLa cell proliferation in
hypoxia (0.5% O2) at 72 hr (Figure S5B). In addi-
tion, HeLa cells in which PDK1 was silenced by
specific siRNA (Figure S5C) showed a decrease
in proliferation under hypoxia (0.5% O2) at 72 hr(Figure S5D) similar to that observed in NDUFA4L2-silenced
cells, suggesting that both NDUFA4L2 and PDK1 play an impor-
tant role in ROS control and cell proliferation in our system
conditions.
MEFs Obtained from NDUFA4L2 Knockout Mice Exhibit
Higher Oxygen Consumption and Complex I Activity
in Hypoxia Than Wild-Type MEFs
In order to gain further insight into the role of NDUFA4L2 on
hypoxia-induced mitochondrial reprogramming, we generated
NDUFA4L2 knockout (KO) mice. We initially planned to isolate
primary cell cultures fromNDUFA4L2-deficient adult mice. How-
ever, we found that homozygous Ndufa4l2 gene inactivation
results in perinatal lethality, which demonstrates an essential
biological role of NDUFA4L2 in development that will be further
explored in future studies. Therefore, we isolated NDUFA4L2-
deficient MEFs and the corresponding wild-type controls from
E12.5–14.5 embryos generated from NDUFA4L2+/ breeding
pairs. In order to validate these MEF cultures, we analyzed the
A B
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Figure 6. Analysis of NDUFA4L2-Deficient MEFs
(A–D) WT and KO MEFs were exposed to 0.5% hypoxia
24 hr prior to subsequent analysis. Immunoblot analysis
showing the total deficiency of NDUFA4L2 is shown in (A).
Tubulin was used as a loading control. Oxygen con-
sumption rates were measured by high-resolution respi-
rometry (Oxygraph 2k) (B). Complex I (C) and Complex IV
(D) activities were measured spectrophotometrically and
expressed relative to citrate synthase values.
(E) Relative growth rates of WT and KO NDUFA4L2 MEFs
cultured in hypoxia (0.5% O2).
(F) Representative images of three independent experi-
ments showing MitoSOX intensity as a measure of mito-
chondrial superoxide levels (n > 3 mean ± SEM; *p < 0.05,
**p < 0.01).
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that NDUFA4L2 increased in hypoxia in MEFs from wild-type
mice only (Figure 6A). We determined oxygen consumption in
MEFs obtained from NDUFA4L2 KO and wild-type mice (Fig-
ure 6B). Confirming results obtained in HeLa cells, MEFs from
NDUFA4L2 KO mice showed increased respiration rate in
hypoxia compared to wild-type mice (Figure 6B). The activity
of Complex I in hypoxia was higher in MEFs from KO mice
than in those from wild-type mice, confirming the results ob-
tained in HeLa cells (Figure 6C). In contrast, the activity of
Complex IV in hypoxia was similarly decreased in both types of
MEFs (Figure 6D). The expression level of respiratory com-
plexes was studied by BN-PAGE using DDM (n-dodecyl beta-
D-maltoside), obtaining the same result as in HeLa cells (data
not shown). In addition, MEFs from NDUFA4L2 KO mice ex-
hibited a lower proliferation rate than those from wild-type
mice when cultured under hypoxia (Figure 6E), and this lower
proliferation correlated with increased ROS production under
hypoxic conditions (Figure 6F).Cell Metabolism 14, 768NDUFA4 Paralogue Is Repressed under
Hypoxia at the Protein Level
It is established that a COX4-2 to COX4-1
subunit substitution takes place at Complex IV
during hypoxia (Fukuda et al., 2007). The pa-
ralogue proteins NDUFA4L2 and NDUFA4
derive from the same ancestral gene, share
more than 65% in their amino acid sequence,
and have been suggested to be part of mito-
chondrial Complex I (Walker et al., 1992). Since
NDUFA4mRNA levels do not change in hypoxia
up to 48 hr (Figure 7A), we investigated the fate
of the protein under hypoxia. We found that
NDUFA4 protein decreases in hypoxic cells
while NDUFA4L2 protein expression increases
in hypoxic conditions (Figure 7B). We also
explored whether NDUFA4L2 levels would be
responsible for the downregulation of NDUFA4.
NDUFA4 protein levels decreased in hypoxia
evenwhen NDUFA4L2was silenced (Figure 7C),
and its expression in normoxia was unaffected
by NDUFA4L2 overexpression (Figure 7D).
NDUFA4 protein decreases to the same extentin NDUFA4L2 KO MEFs, demonstrating that both events occur
independently (Figure 7E). Collectively, all these data indicate
that NDUFA4L2 KO MEFs markedly repress NDUFA4 protein
levels in hypoxia while Complex I activity is not affected, ruling
out the possibility that Complex I activity is repressed in hyp-
oxia via NDUFA4. These data stress the specific role of
hypoxia-dependent NDUFA4L2 upregulation in Complex I
activity inhibition.
DISCUSSION
The influence of fluctuations in oxygen concentration on mito-
chondrial activity has raised a great interest due to its broad
impact on pathophysiology. Mitochondrial respiration is only
compromised when the oxygen concentration drops below
0.1% O2 because of the high affinity of mitochondrial cyto-
chrome c oxidase (Complex IV) for oxygen (Aguirre et al., 2010;
Gnaigeretal., 1998;Smolenskiet al., 1991;StumpeandSchrader,
1997). However, during moderate hypoxia (1%–2% O2), cells–779, December 7, 2011 ª2011 Elsevier Inc. 775
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Figure 7. Opposite Regulation of NDUFA4 and
NDUFA4L2 under Hypoxia
(A) HeLa cells were cultured under hypoxia (1% O2) for 6,
12, 24, and 48 hr, and NDUFA4 mRNA levels were
analyzed.
(B) Immunoblot analysis of HeLa cells subjected to either
24 or 48 hr of hypoxia and proved against NDUFA4 and
NDUFA4L2 antibodies. NDUFA9 was used as a loading
control for Complex I, and tubulin was used as a total
loading control.
(C and D) HeLa cells were transfected with a scramble
control or NDUFA4L2 siRNA and then exposed to nor-
moxic or hypoxic (1% O2) conditions for 24 hr (C) or
transfected with the empty or pCMV-NDUFA4L2 vector
(D). Cell lysates were analyzed against NDUFA4,
NDUFA4L2, and tubulin antibodies.
(E) Immunoblot analysis of MEFs WT and KO for
NDUFA4L2 showing the total deficiency of NDUFA4L2
and the decrease of NDUFA4 under hypoxic (1% O2)
conditions for 24 hr. Tubulin was used as a loading control.
(F) Model showing the involvement of NDUFA4L2 induc-
tion by HIF-1a in hypoxic adaptation. HIF-1a stabilization
by hypoxia upregulates NDUFA4L2, which inhibits ETC
Complex I activity. As a result, oxygen consumption de-
creases and ROS production is abrogated, thereby
allowing cells to adapt to the hypoxic conditions. In con-
trast, hypoxia decreases NDUFA4 protein levels (n > 3;
mean ± SEM; *p < 0.05; **p < 0.01).
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NDUFA4L2 Controls Mitochondrial Complex I Activityexpress a large number of genes, dependent on HIFs, that repro-
gram the metabolism to attenuate mitochondrial O2 consump-
tion, which also protects cells against excessive mitochondrial
ROS formation (Aragone´s et al., 2009; Kim et al., 2006; Papan-
dreou et al., 2006).
At the molecular level, we show here that moderate hypoxia
decreases oxygen consumption and Complex I activity via the
HIF-1-dependent upregulation of NDUFA4L2. Our data indicate
that NDUFA4L2 is a HIF-1-dependent gene, emphasizing the
role of HIF-1 in mitochondrial reprogramming and revealing
NDUFA4L2 as an important element in metabolic adaptation to
hypoxia. We have observed this induction in different cell types,
as well as in tissue from animals subjected to hypoxia, suggest-
ing a role in physiological adaptation to hypoxia. In this regard,
NDUFA4L2 KO homozygous mice, which could be a presumed
mouse model of Complex I gain of function based on our own
data, show perinatal lethality, stressing the high relevance of
this protein in vivo. Similarly, mouse models of Complex I defi-
ciency (Kruse et al., 2008) also die shortly after birth, which indi-
cates that Complex I activity needs to be tightly controlled to
assure an adequate development early after birth.
The PHDoxygen-sensing pathway is also known to upregulate
the PDH kinase isoforms PDK1, PDK3, and PDK4 (Aragone´s
et al., 2008; Kim et al., 2006; Lu et al., 2008; Papandreou et al.,
2006). PDK overactivation reduces PDH activity, slowing down
the conversion of pyruvate into acetyl-CoA and ultimately re-
pressing the TCA cycle and the supply of NADH to themitochon-
drial ETC. Therefore, PDKs could potentially cooperate with
NDUFA4L2 to reduce mitochondrial Complex I activity under
moderate hypoxic conditions, but it is also conceivable that
NDUFA4L2 has other biological functions that cannot be accom-776 Cell Metabolism 14, 768–779, December 7, 2011 ª2011 Elsevierplished by PDKs. For example, when metabolites that fuel the
TCA cycle originate from pathways different from glycolysis
(e.g., glutaminolysis or fatty acid oxidation), it would be neces-
sary to reduce ETC activity in order to decrease mitochon-
drial function (Wheaton and Chandel, 2011). Hypoxia-induced
NDUFA4L2 expression could fulfill this role, reducing oxygen
consumption due to its strategic position downstream of the
TCA cycle, possibly at Complex I (Figure 7F). Likewise, hypoxia
induces the upregulation of microRNA-210, which represses
ISCU1/2 (Chan et al., 2009; Chen et al., 2010; Favaro et al.,
2010). These proteins facilitate the assembly of iron-sulfur clus-
ters, including those in Complex I, Complex III, and aconitase,
which are critical for electron transport and mitochondrial redox
reactions. As a result, microRNA-210 represses mitochondrial
respiration. In our model, and in line with previous studies,
ISCU1/2 protein does not decrease prior to 48 hr and only under
0.5% O2, while NDUFA4L2 becomes functional as early as 24 hr
at 1%O2. Moreover, ISCU1/2 recovery in hypoxic HeLa cells did
not disturb proliferation. In this sense, it has been described that
an anti-miR-210 affects HeLa cell proliferation at times longer
than 48 hr and at very low oxygen tensions (0.01% O2) (Favaro
et al., 2010).
Very intriguingly, however, Complex I inhibition in HeLa cells
takes place at milder hypoxia (1% O2) (Figure 4), and this
oxygen tension does not seem to be enough to decrease
ISCU1/2 (Figure S5A). Furthermore, ISCU1/2 downregulation is
not observed before 48 hr, but Complex I is inhibited as early
as 24 hr. This opened a 24 hr window during which NDUFA4L2
could be acting before ISCU induction takes place. As demon-
strated, NDUFA4L2 Complex I inhibition occurs without af-
fecting Complex I quantity, but probably by a direct or indirectInc.
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targeted ISCU1/2 presumably fulfills its function by decreasing
Complex I content. This early NDUFA4L2-dependent qualitative
modulation followed by a later miR210-dependent quantitative
repression of Complex I represents a possible model by which
HIF-1 guarantees a fine control of Complex I under hypoxic
conditions. In summary, we propose that, although NDUFA4L2
upregulation and miR-210-induced ISCU1/2 repression could
act synergistically to decrease Complex I activity and oxygen
consumption in chronic hypoxia, we should underscore that
primary (1% O2) Complex I inhibition can be only accomplished
by early NDUFA4L2 induction.
Altered subunit content during hypoxia has also been reported
for other ETC complexes. Thus, physiological hypoxia induces
a COX4-1 to COX4-2 subunit switch, an effect mediated by
HIF-1 that is thought to optimize the efficiency of respiration
during conditions of reduced oxygen availability (Fukuda et al.,
2007). Since we have found that NDUFA4 is downregulated at
the protein level in hypoxia, we could speculate that NDUFA4L2
induction is taking over NDUFA4’s place at Complex I and
reducing in some way its activity. However, NDUFA4L2 KO
MEFs markedly repress NDUFA4 protein levels in hypoxia, while
Complex I activity is not affected, ruling out the possibility that
Complex I activity is repressed in hypoxia via NDUFA4. In this
regard, the role and location of NDUFA4 within Complex I are
not yet well understood.
The ETC produces superoxide when single electrons are
transferred to O2 during electron transport. There are different
sites of ROS production in mammalian mitochondria (Murphy,
2009), but the greatest maximum capacity of ROS production
is the ubiquinone reduction site of Complex I and the outer
quinone-binding site of the Q cycle in Complex III (Liu et al.,
2002; Raha and Robinson, 2000; St-Pierre et al., 2002; Votya-
kova and Reynolds, 2001). Although superoxide production in
isolated mitochondria correlates with oxygen tension (Liu et al.,
2002), it is generally accepted that ROS production in cells
increases during short periods of hypoxia (Brunelle et al., 2005;
Guzy et al., 2005; Mansfield et al., 2005). In agreement with
this, we detected increased ROS in hypoxia using the fluores-
cent probes DCFDA and MitoSOX. The hypoxia-induced ROS
increase was exacerbated in the absence of NDUFA4L2, indi-
cating that the expression of this protein keeps ROS production
under control and hence could protect the cell against oxidative
stress.Whether the effects of NDUFA4L2 on ROS production are
direct or occur through the modulation of other mitochondrial
proteins requires further research. However, the fact that mito-
chondrial membrane potential increases simultaneously with in-
creased ROS in the absence of NDUFA4L2 suggests that both
events might be closely associated, as has been demonstrated
elsewhere (Korshunov et al., 1997; Votyakova and Reynolds,
2001).
Hypoxia-exposed cell cultures accumulate intracellular ROS,
but most probably at lower sublethal concentrations. As shown
in Figure 5, and in line with previous studies, hypoxia slows
down proliferation (Gardner et al., 2001; Goda et al., 2003).
However, NDUFA4L2-silenced cells and MEFs from NDUFA4L2
KO mice showed a more profound inhibition of cell prolifera-
tion in parallel to a higher ROS accumulation and DNA stress/
damage (H2AX phosphorylation) than control cells or MEFsCell Mfrom wild-type mice. NDUFA4L2-silenced cells did not show
signs of cellular apoptosis, probably because of the high-resis-
tance nature of these tumor cells. Therefore, it is reasonable to
think that the PHD-HIF system counteracts ROS overproduction
that impairs cell growth.
Several in vivo and in vitro studies have revealed that the
reduction of mitochondrial oxygen consumption through PHD
and HIF activities prepares cells to tolerate more extreme lethal
hypoxic/ischemic conditions, saving oxygen and reducing mito-
chondrial ROS formation. We hypothesize that NDUFA4L2
induction during hypoxia helps keep intracellular ROS produc-
tion in check, consistent with the fact that NDUFA4L2 limits
Complex I activity and prevents increases in membrane poten-
tial. It is therefore reasonable to speculate that NDUFA4L2 could
participate in ischemic preconditioning. Indeed, several in vivo
studies have shown that partial inhibition of Complex I with sub-
lethal doses of amobarbital (a reversible inhibitor at the rotenone
site of Complex I) prevents reperfusion-induced cardiac damage
(Aldakkak et al., 2008; Chen et al., 2006a, 2006b).
Our studies indicate that mitochondrial Complex I activity is
controlled by NDUFA4L2 during hypoxia. In conjunction with
previous data on PHD- and HIF-regulated mitochondrial activity,
we add further elements to the strategic armory used by HIFs to
ensure that mitochondrial oxygen consumption is repressed in
mild hypoxic conditions, highlighting the biological relevance of
the regulation of this cellular response.
EXPERIMENTAL PROCEDURES
Cell Lines and Cultures
HeLa, RCC4, RCC4/VHL, PC-12, HL-1, neonatal rat cardiomyocytes, Hif-
1a+/+/Cre or Hif-1a+f/+f/Cre MEFs, and human umbilical vein endothelial cells
(HUVEC) were used. See Supplemental Experimental Procedures for details.
Microarray Analysis
Total RNA was extracted using Ultraspec reagent (Biotecx, Houston, TX).
One-Color Microarray-Based Gene Expression Analysis Protocol (Agilent
Technologies, Palo Alto, CA) was used to amplify and label RNA. Briefly,
200–700 ng of total RNA was reverse transcribed using T7 promoter Primer
andMMLV-RT. Then cDNAwas converted to aRNA using T7 RNA polymerase,
which simultaneously amplifies target material and incorporates cyanine
3-labeled CTP. Samples were hybridized to Whole Human Genome Micro-
array 43 44K (G4112F, Agilent Technologies). Cy3-labeled aRNA (1.65 g) was
hybridized for 17 hr at 65C in a hybridization oven (G2545A, Agilent) set to
10 rpm in a final concentration of 13 GEx Hybridization Buffer HI-RPM,
according to manufacturer’s instructions (One-Color Microarray-Based
Gene Expression Analysis, Agilent Technologies). Arrays were washed ac-
cording to manufacturer’s instructions (One-Color Microarray-Based Gene
Expression Analysis, Agilent Technologies) and dried out using a cen-
trifuge. Finally, arrays were scanned at 5 mm resolution on an Agilent DNA
Microarray Scanner (G2565BA, Agilent Technologies) using the default
settings for 43 44K format one-color arrays. Images provided by the scanner
were analyzed using Feature Extraction software version 9.5.3.1 (Agilent
Technologies).
In Vivo Hypoxia Experiments
Eight-week-old male C57BL/6 mice were exposed to hypoxic (7.5% O2) or
normoxic (21% O2) conditions for 18 hr. After treatment mice were sacrificed
under the same conditions to avoid tissue reoxygenation following hypoxia.
The brain and heart were then excised, frozen in liquid nitrogen, and stored
at 80C. Organs were homogenized in liquid nitrogen and resuspended in
RIPA buffer (1% NP40, 0.5% sodium deoxycholate, and 0.1% SDS in PBS
buffer) for protein extraction or Ultraspec reagent (Biotecx, Houston, TX) for
mRNA isolation.etabolism 14, 768–779, December 7, 2011 ª2011 Elsevier Inc. 777
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Oxygen consumption was determined by high-resolution respirometry
(Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria). Cells were trypsi-
nized after the indicated treatments and then resuspended at 23 106 cells/ml
in HBSS containing 25 mM HEPES. The instrumental background flux was
calculated as a linear function of the oxygen concentration, and the experi-
mental data were corrected using DatLab software (Oroboros Instruments).
The oxygen concentration in air-saturated culture medium at 37C was
175.7 mM (Rodrı´guez-Jua´rez et al., 2007). Measurements were taken at 37C
in parallel Oxygraph-2k chambers for cells incubated in normoxic and hypoxic
(1% O2) conditions with the indicated treatments.
Mitochondria Isolation
The isolation of an enriched mitochondrial fraction from 2–5 3 107 HeLa cells
was performed using the Mitochondria Isolation Kit MITOISO2 (Sigma)
according to the manufacturer’s instructions.
Complex I and IV Activity
The activities of Complex I and Complex IV were measured using the Complex
I Enzyme Activity Microplate Assay Kit or the Complex IV Human Duplexing
Microplate Assay Kit, both from MitoSciences, according to the manufac-
turer’s instructions.
Mitochondrial Membrane Potential
Mitochondrial membrane potential was determined by incubating the cells
with the fluorescent dye tetramethylrhodamine ethyl ester (TMRE; Sigma).
Cells were incubated with 2.5 nM TMRE for 30 min at 37C and subsequently
analyzed by FACScan flow cytometer (Becton Dickinson, Lincoln Park, NJ).
Cell Proliferation and Apoptosis
For the cell proliferation assay, 2 3 105 HeLa, HUVEC, UCD-mel-N, and
SKOV3 cells were planted in a 10 cm dish 1 day before exposure to hypoxic
conditions (0.5% O2). Either 0.1 mM NAC or 0.5 mM Mito-Q (0.5 mM DTPP
was used as control of Mito-Q) was added to HeLa cells to determinate the
effect of the antioxidants on NDUFA4L2-interfered cell proliferation in hypoxia.
At the times indicated, the cells were trypsinized and the viable cells were
counted using trypan blue. Apoptosis was determined by flow cytometry anal-
ysis of the cell cycle after DNA staining with propidium iodide (PI) and by anal-
ysis of cleaved caspase-3 with a specific antibody (Cell Signaling). Positive
controls for apoptosis were performed by incubating HeLa cells with taxol
(Calbiochem) at 1 mg/ml for 18 hr.
Soft Agar Assay
HeLa cells were seeded into 0.35% agar Noble (Difco) in DMEM containing
10% heat-inactivated FBS on top of a bed of 0.5% agar in 60 mm dishes at
53 103 cells per dish. Immobilized cells were grown for 15 days in a humidified
chamber at 37C and exposed to normoxic or hypoxic conditions (0.5% O2).
Colonies were then photographed using a DS-Fi1 camera (Nikon) and counted
and measured using ImageJ software.
Analysis of ETC Complexes by Blue Native Electrophoresis Gel
Mitochondrial membrane proteins (100–150 mg) were applied and run on a
3%–13%first-dimension gradient Blue native electrophoresis gel as described
elsewhere (Scha¨gger, 1995). After electrophoresis, the complexes were elec-
troblotted onto PVDF filters and sequentially probed with the following specific
antibodies: anti-NDUFA9 (complex I), anti-core2 (complex III), anti-COI (com-
plex IV), and anti-70 kDa subunit (complex II). All antibodies were obtained
from Molecular Probes.
Ndufa4l2 Gene Inactivation in Mice
NDUFA4L2 chimeric males were obtained from Velocigene Regeneron Phar-
maceuticals, Inc. (Reference number: 13661) through the KOMP repository.
These chimeric mice were crossed with wild-type C57BL/6 females to
generate NDUFA4L2 heterozygous mice. NDUFA4L2 heterozygous mice
were used to generate NDUFA4L2-deficient embryos and the subsequent
murine embryonic fibroblast isolation. The mice were bred and housed in
a specific pathogen free (SPF) animal area of the animal facility at the Univer-
sidad Auto´noma de Madrid (UAM).778 Cell Metabolism 14, 768–779, December 7, 2011 ª2011 ElsevierStatistical Analysis
The data are presented as the means ± SEM of at least three independent
experiments. Statistical significance *p < 0.05 or **p < 0.01 was assessed by
the Wilcoxon test.ACCESSION NUMBERS
The microarray data of HeLa cells are deposited at GEO DataSets with the
accession number GSE33521.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, five tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2011.10.008.
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